Infliximab treatment in refractory Kawasaki syndrome
| Autor: | Meenakshi Girish, Girish Subramaniam |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
Systemic disease medicine.medical_specialty Pediatrics Anti-Inflammatory Agents Mucocutaneous Lymph Node Syndrome Refractory hemic and lymphatic diseases Immunopathology medicine Humans cardiovascular diseases skin and connective tissue diseases Coronary artery aneurysm Vascular disease business.industry Antibodies Monoclonal medicine.disease Infliximab Surgery Treatment Outcome Child Preschool Pediatrics Perinatology and Child Health Kawasaki disease Vasculitis business medicine.drug |
| Zdroj: | The Indian Journal of Pediatrics. 75:521-522 |
| ISSN: | 0973-7693 0019-5456 |
| Popis: | Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink